Scalper1 News
Shares of device maker Edwards Lifesciences (EW) jumped 14% in early trading in the stock market today after word got out late Friday that the company had won a court injunction limiting the sale of Medtronic’s (MDT) CoreValve artificial heart valve in the U.S. Medtronic stock was down 3%. CoreValve, which has been sold in Europe for several years, was approved by the FDA in January. But Edwards, whose rival Sapien product has been sold in America Scalper1 News
Scalper1 News